FDA Brief

Company record

Aytu Biopharma

2 FDA warning letters since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Aytu Biopharma.

Warning letters

  1. Aytu Biopharma

    FDA says Aytu Biopharma’s sponsored links for ADHD drug Cotempla XR-ODT are false or misleading and misbrand it.

    High risk
  2. Aytu Biopharma

    FDA warned Aytu Biopharma that sponsored links for ADHD drug Adzenys XR-ODT are false or misleading because they omit risk information.

    High risk